HCC in young adults

Hepato-Gastroenterology

Volumn 57, Issue 99-100, 2010, Pages 436-440

  Carr, Brian I ^a   Pancoska, Petr ^b   Branch, Robert A ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

AFP; Field defect; GGTP; HCC; Young

Indexed keywords

ALPHA FETOPROTEIN; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER NEOPLASMS; MALE; YOUNG ADULT;

EID: 77955503085     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Okuda K, Ohtsuki T, Obata H, et al: Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56: 918-928.
2. The Cancer of the Liver Italian Program (CLIP): Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Investigators. Hepatology. 2000;31:840-845.
3. Marrero JA, Fontana RJ, Barrat A, et al: Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41:707-716.
4. Carr BI, Buch SC, Kondragunta V, Pacoska P, Branch RA: Tumor and liver determinants of prognosis in unresectable HCC: a case cohort study. J Gastroenterology Hepatology 2008;23:1259-1266
5. Carr BI, Pancoska P and Branch RA: A novel approach to analysis of prognosis in patients with unresectable HCC from a large clinical dataset. Hepatology International 2009; 4:396-405.
6. Buch SC, Kondragunta V, Branch RA and Carr BI: Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatology International 2008. 2. 95-101
7. Carr BI, Pancoska P, Branch RA: HCC in older age. Dig. Dis. Sci. 2010; Mar 18: Epub.
8. Pancoska P, Carr BI, Branch RA: Network-based analysis of survival for unresectable hepatocellular carcinoma. Seminars in Oncology April 2010 (in press).
9. Carr BI, Kondragunta V, Buch S, Branch R: Therapeutic equivalence in survival for hepatic arterial chemoembolization and 90Yttrium microspheres (Y90) treatments in unresectable HCC. Cancer 2010; 116:1305-1314.
10. Steyerberg EW. Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating: SBH/Statistics for Biology and Health. Springer, 2009.
11. Rizzo R and Maria L: Statistical computing. Chapman & Hall/CRC Press (Computer Science and Data Analysis C5450, 2007).
12. Everitt BS and Hothorn T: A Handbook of Statistical Analyses using R. Second Edition (Ch. 5,6-7,10)..Chapman & Hall/CRC Press (C7933, 2009))
13. Witten IH and Eibe F: Data Mining: Practical Machine Learning Tools and Techniques. (Chapters 4,6 and 9, Second Ed.), Frank.Morgan Kaufmann Publishers, (San Francisco, Oxford, 2005)).
14. Maplesoft. Maple, ed. 12 Ontario, Canada N2V 1K8, Statistics with Maple, Elsevier Sciences, Academic Press (San Diego, London, 2003).
15. Utsonomiya T, Shimada M, Imura S, Morine Y, Ikemoto T, Mori M: Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma. J. Gastroenterol. 2010: 45: 146-152
16. Sherman M: Recurrence of hepatocellular carcinoma. N.Engl.J.Med. 2008; 359: 2045-2047
17. Hoshida, Y, Villaneuva A, Kobayashi M et al: N.Engl. J.Med 2008; 359: 1995-2004.
18. Yen YH, Changchien CS, Wang JH, Kee KM, Hung CH, Hu TH, Lee CM, Lin CY, Wang CC, Chen TY, Huang YJ, Lu SN. A modified TNM-based Japan Integrated Score combined with AFP level may serve as a better staging system for early-stage predominant hepatocellular carcinoma patients. Dig Liver Dis. 2009;41:431-41.
19. Nomura F, Ohnishi K, Tanabe Y: Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients. Cancer. 1989;64:1700-7. Review.
20. Peng SY, Chen WJ, Lai PL, Jeng YM, Sheu JC, Hsu HC: High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations. Int J Cancer. 2004;112:44-50.
21. Chan SL, Mo FK, Johnson PJ, Hui EP, Ma BB, Ho WM, Lam KC, Chan AT, Mok TS, Yeo W: New utility of an old marker: serial alpha-fetoprotein measurement in predicting radiologic response and survival of patients with hepatocellular carcinoma undergoing systemic chemotherapy. J.Clin Oncol. 2009 ;27:446-52.
22. Ju MJ, Qiu SJ, Fan J, Zhou J, Gao Q, Cai MY, Li YW, Tang ZY: Preoperative serum gamma-glutamyl transferase to alanine aminotransferase ratio is a convenient prognostic marker for Child-Pugh A hepatocellular carcinoma after operation. J Gastroenterol. 2009;44:635-42.
23. Yao DF, Huang ZW, Chen SZ, Huang JF, Lu JX, Xiao MB, Meng XY: Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase. Am J Clin Pathol. 1998;110:743-9.
24. Cui R, He J, Zhang F, Wang B, Ding H, Shen H, Li Y, Chen X: Diagnostic value of protein induced by vitamin K absence (PIVKAII) and hepatoma-specific band of serum gamma-glutamyl transferase (GGTII) as hepatocellular carcinoma markers complementary to alpha-fetoprotein. Br J Cancer. 2003;88:1878-82.